Drug Discovery Services for Leukemia

Functional Roles of Drug Discovery in Leukemia

Drug development offers a promising approach to tackling leukemia, but it is a complex and time-consuming process that involves multiple stages and extensive research and development efforts. Moreover, the diversity and complexity of the disease further complicate the drug discovery process. Collaborating with specialized companies in leukemia drug development can expedite the process and reduce research time. Target-based drug development and phenotypic screening-based drug discovery are two approaches that yield a range of potential drug candidates for leukemia treatment.

Fig. 1. FDA-approved drugs for the treatment of acute myeloid leukemia (AML). (Totiger, T.M. et al., 2023)

Services in Drug Discovery for Leukemia

Alfa Cytology provides research services for leukemia drug discovery to support your development of new treatments for leukemia. We can optimize and build new and suitable solutions for you for different types of leukemia. at the same time, we can also provide you with consulting services and effective advice. We focus on drug development for leukemia and provide professional solutions for drug development for leukemia. The services we provide involve drug target identification, high-throughput screening, identification and optimization of active compounds, drug metabolism and pharmacokinetic assessment, toxicological assessment, and animal model studies.

According to different research contents, we provide you with the following services.

Drug Target Identification and Validation for Leukemia

In the drug discovery of leukemia, it is necessary to identify proteins, enzymes, or signal pathways that are suitable as therapeutic targets.

High Throughput Drug Screening of Leukemia

In the process of drug discovery, researchers will use high-throughput screening (HTS) technology to screen a large library of compounds to find compounds with antileukemic activity.

In Vitro Pharmacology Services for Leukemia

Drug tests were carried out in vitro to evaluate the efficacy of candidate drugs on target cells or tissues in vitro.

In Vivo Pharmacology Services for Leukemia

Through the animal model of leukemia, the effect of drugs in a complex in vivo environment was evaluated.

DMPK and ADME Services for Leukemia Drugs

In the process of preclinical discovery, it is necessary to evaluate the metabolic characteristics and pharmacokinetic properties of the drug to determine the behavior and metabolic pathway of the drug in vivo.

Toxicology Services for Leukemia Drugs

Drug discovery requires a toxicological assessment of drugs to assess their potential toxicity and safety.

Leukemia Colony-Forming Cell Assay Services

We offer colony-forming cell assay services aimed at identifying leukemic colonies and assessing the toxicity of leukemic drugs.

Customized Services

In addition, we also provide customized services to provide you with your solutions. For more details, please send us your inquirydirectly.

Advantages of Our Services

Our scientific research team is of high quality and adheres to the highest quality standards to complete the project.
We provide cutting-edge biotechnology to support your latest research.
We provide a full range of customized services covering different types of drugs.
A variety of cell culture forms and models can be used for targeted experiments.
We have rich experience in leukemia drug development and have helped customers complete several leukemia drug development projects.

Partner with Alfa Cytology to leverage our expertise in leukemia drug development. Our services encompass all critical aspects, empowering you with the necessary tools and knowledge to advance your drug discovery efforts for leukemia treatment. Contact us to discuss your specific requirements and explore the wide range of services we can provide for you.

Reference

Totiger, T.M.; et al. Targeted Therapy Development in Acute Myeloid Leukemia. Biomedicines. 2023, 11(2): 641.

For research use only. Not intended for any clinical use.